{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:59:52Z","timestamp":1753891192631,"version":"3.41.2"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022762","name":"Universitat Witten\/Herdecke","doi-asserted-by":"publisher","award":["UW\/H-IFF-2025-02, UW\/H-IFF-2023-62"],"award-info":[{"award-number":["UW\/H-IFF-2025-02, UW\/H-IFF-2023-62"]}],"id":[{"id":"10.13039\/100022762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EH 192\/5-3"],"award-info":[{"award-number":["EH 192\/5-3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The development of mucosal adenovirus (Ad) vaccine vectors is considered one of the next frontiers to protect vulnerable patients from respiratory and gastrointestinal pathogens. An efficient delivery to or through the oral cavity necessitates a thorough understanding of Ad interactions with saliva for oral, buccal or sublingual vaccine delivery, which could additionally prove instrumental in the containment of natural Ad infections but remains unexplored. Therefore, we investigated the influence of saliva on Ad infectivity, emphasizing its intrinsic antiviral role against particular Ad types in various epithelial cell cultures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A saliva pool was created from healthy donors (<jats:italic>n<\/jats:italic>=16) and incubated with ChAdOx1 or human Ads from 20 different types prior to infection of human immortalized epithelial cells. All human Ads used were replication-competent and expressed a GLN cassette containing a green-fluorescent protein, nano-luciferase, and neomycin resistance. Loss-of-function experiments were conducted by immunoprecipitation or enzymatic digestion of specific saliva components to decipher related mechanisms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Temporal and inter-individual variability in saliva samples were observed, validating the use of a saliva pool to represent the population. Saliva strongly influenced Ad infectivity, in general through inhibiting species B types and enhancing species D and E Ads, that include the vaccine vector platforms Ad26 and ChAdOx1. Interestingly, Ad20 presented the highest infectivity enhancement, as well as superior to average salivary mucus crossing rates. Furthermore, saliva immunoglobulins and human neutrophil peptides marginally influenced the Ad infectivity, while sialic acid inhibited all tested Ad types.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Saliva may have a protective role against infection by certain types of Ads. This discovery highlights a potential limitation in the efficacy of next-generation oral Ad vaccine vectors. Consequently, our study underscores the importance of identifying and utilizing saliva-resistant Ad vectors to optimize Ad-based vaccination strategies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1579896","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:54:12Z","timestamp":1749635652000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Human saliva exerts strong type-dependent effects on adenovirus infectivity"],"prefix":"10.3389","volume":"16","author":[{"given":"Erwan","family":"Sallard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikita","family":"Chilakamarri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setareh","family":"Farzanehkari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inga Marte Charlott","family":"Seuthe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Ehrhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malik","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"B1","unstructured":"Human adenovirus working group\n          \n          2024"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1086\/320146","article-title":"Lower respiratory tract infections due to adenovirus in hospitalized korean children: Epidemiology, clinical features, and prognosis","volume":"32","author":"Hong","year":"2001","journal-title":"Clin Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1556\/EuJMI.4.2014.1.2","article-title":"Human adenovirus: Viral pathogen with increasing importance","volume":"4","author":"Ghebremedhin","year":"2014","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/s41541-023-00717-8","article-title":"Phase iii pivotal comparative clinical trial of intranasal (incovacc) and intramuscular covid 19 vaccine (covaxin((r)))","volume":"8","author":"Singh","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B5","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-2600(22)00087-X","article-title":"Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised ad5-ncov after two-dose priming with an inactivated sars-cov-2 vaccine in chinese adults: A randomised, open-label, single-centre trial","volume":"10","author":"Li","year":"2022","journal-title":"Lancet Respir Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines - fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1388222","article-title":"Cutting-edge research frontiers in oral cavity vaccines for respiratory diseases: A roadmap for scientific advancement","volume":"14","author":"Sallard","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5005\/jcdp-9-3-72","article-title":"Saliva composition and functions: A comprehensive review","volume":"9","author":"de Almeida Pdel","year":"2008","journal-title":"J Contemp Dent Pract"},{"key":"B9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/00016358209041120","article-title":"Concentration of immunoglobulins in human whole saliva: Effect of physiological stimulation","volume":"40","author":"Gronblad","year":"1982","journal-title":"Acta Odontol Scand"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.9.3883-3888.2005","article-title":"Salivary antimicrobial peptide expression and dental caries experience in children","volume":"49","author":"Tao","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1039\/c7ay01676j","article-title":"High performance liquid chromatography coupled to electrospray ionisation mass spectrometry method for the detection of salivary human neutrophil alpha defensins hnp1, hnp2, hnp3 and hnp4","volume":"9","author":"Ashrafi","year":"2017","journal-title":"Analytical Methods"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000959","article-title":"Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization","volume":"6","author":"Smith","year":"2010","journal-title":"PloS Pathog"},{"key":"B13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.chom.2007.12.001","article-title":"Mechanism of adenovirus neutralization by human alpha-defensins","volume":"3","author":"Smith","year":"2008","journal-title":"Cell Host Microbe"},{"key":"B14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s0167-0115(01)00282-8","article-title":"Human alpha-defensin 1 (hnp-1) inhibits adenoviral infection","volume":"101","author":"Bastian","year":"2001","journal-title":"vitro. Regul Pept"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.74.13.6050-6057.2000","article-title":"Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer","volume":"74","author":"Pickles","year":"2000","journal-title":"J Virol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1165\/ajrcmb.17.4.2714","article-title":"Muc1 and other sialoglycoconjugates inhibit adenovirus-mediated gene transfer to epithelial cells","volume":"17","author":"Arcasoy","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.74.16.7691-7693.2000","article-title":"Initial interactions of subgenus d adenoviruses with a549 cellular receptors: Sialic acid versus alpha(v) integrins","volume":"74","author":"Arnberg","year":"2000","journal-title":"J Virol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1034\/j.1600-0722.2002.11175.x","article-title":"Inhibition of hiv-1 iiib and clinical isolates by human parotid, submandibular, sublingual and palatine saliva","volume":"110","author":"Bolscher","year":"2002","journal-title":"Eur J  Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/scitranslmed.abd2223","article-title":"Iga dominates the early neutralizing antibody response to sars-cov-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci Transl Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1399-302X.2008.00468.x","article-title":"Multiple components contribute to ability of saliva to inhibit influenza viruses","volume":"24","author":"White","year":"2009","journal-title":"Microbiol Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.celrep.2017.05.008","article-title":"An engineered virus library as a resource for the spectrum-wide exploration of virus and vector diversity","volume":"19","author":"Zhang","year":"2017","journal-title":"Cell Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"105.3390\/ijms21176370","DOI":"10.3390\/ijms21176370","article-title":"High-throughput cloning and characterization of emerging adenovirus types 70, 73, 74, and 75","volume":"21","author":"Zhang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.xphs.2022.12.012","article-title":"Measurement of adenovirus-based vector heterogeneity","volume":"112","author":"Hickey","year":"2023","journal-title":"J Pharm Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.7883\/yoken.65.457","article-title":"Isolation of an intertypic recombinant human adenovirus (candidate type 56) from the pharyngeal swab of a patient with pharyngoconjunctival fever","volume":"65","author":"Enomoto","year":"2012","journal-title":"Jpn J Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.17.11259-11268.2005","article-title":"Cd46-utilizing adenoviruses inhibit c\/ebpbeta-dependent expression of proinflammatory cytokines","volume":"79","author":"Iacobelli-Martinez","year":"2005","journal-title":"J Virol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"134425","DOI":"10.1038\/s41598-018-31713-x","article-title":"Human adenovirus type 17 from species d transduces endothelial cells and human cd46 is involved in cell entry","volume":"8","author":"Liu","year":"2018","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nm952","article-title":"Cd46 is a cellular receptor for group b adenoviruses","volume":"9","author":"Gaggar","year":"2003","journal-title":"Nat Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"Wang","year":"2011","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1128\/JVI.74.1.42-48.2000","article-title":"Adenovirus type 37 uses sialic acid as a cellular receptor","volume":"74","author":"Arnberg","year":"2000","journal-title":"J Virol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12985-020-01318-w","article-title":"Identification of novel human adenovirus candidates using the coxsackievirus and adenovirus receptor for cell entry","volume":"17","author":"Mese","year":"2020","journal-title":"Virol J"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00836-22","article-title":"Adenovirus infections: New insights for the clinical laboratory","volume":"62","author":"Kajon","year":"2024","journal-title":"J Clin Microbiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/08830185.2013.823420","article-title":"Adenoviruses types, cell receptors and local innate cytokines in adenovirus infection","volume":"33","author":"Chen","year":"2014","journal-title":"Int Rev Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.virusres.2009.02.010","article-title":"Adenovirus receptors and their implications in gene delivery","volume":"143","author":"Sharma","year":"2009","journal-title":"Virus Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3576","article-title":"Development of oncolytic and gene therapy vectors based on adenovirus serotype 4 as an alternative to adenovirus serotype 5","volume":"26","author":"Sallard","year":"2024","journal-title":"J Gene Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.omtm.2019.07.001","article-title":"Enhanced tropism of species b1 adenoviral-based vectors for primary human airway epithelial cells","volume":"14","author":"Li","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.coviro.2018.12.004","article-title":"Emergence and re-emergence of respiratory adenoviruses in the United States","volume":"34","author":"Kajon","year":"2019","journal-title":"Curr Opin Virol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"105.1126\/sciimmunol.aau2710","DOI":"10.1126\/sciimmunol.aau2710","article-title":"Prolonged evolution of the memory b cell response induced by a replicating adenovirus-influenza h5 vaccine","volume":"4","author":"Matsuda","year":"2019","journal-title":"Sci Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"105.1172\/JCI140794","DOI":"10.1172\/JCI140794","article-title":"A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity","volume":"131","author":"Matsuda","year":"2021","journal-title":"J Clin Invest"},{"key":"B39","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.addr.2017.07.019","article-title":"The role of mucus in cell-based models used to screen mucosal drug delivery","volume":"124","author":"Lechanteur","year":"2018","journal-title":"Adv Drug Delivery Rev"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.145","article-title":"International epidemiology of human pre-existing adenovirus (ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high ad5 titers and implications for potential hiv vaccine trials","volume":"28","author":"Mast","year":"2010","journal-title":"Vaccine"},{"key":"B41","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1021\/ac801609r","article-title":"Comprehensive defensin assay for saliva","volume":"81","author":"Gardner","year":"2009","journal-title":"Anal Chem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.1186\/s12903-022-02686-1","article-title":"Comparison of proteins with anti-influenza virus effects in parotid and submandibular-sublingual saliva in humans","volume":"22","author":"Yamamoto","year":"2022","journal-title":"BMC  Health"},{"key":"B43","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.2041-1014.2012.00650.x","article-title":"Salivary proteins promote proteolytic activity in streptococcus mitis biovar 2 and streptococcus mutans","volume":"27","author":"Kindblom","year":"2012","journal-title":"Mol  Microbiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/bmb.21825","article-title":"Detection and enzymatic characterization of human saliva amylase","volume":"52","author":"Vey","year":"2024","journal-title":"Biochem Mol Biol Educ"},{"key":"B45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1196\/annals.1384.030","article-title":"Salivary proteome and its genetic polymorphisms","volume":"1098","author":"Oppenheim","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013352","article-title":"Individual differences in amy1 gene copy number, salivary alpha-amylase levels, and the perception of oral starch","volume":"5","author":"Mandel","year":"2010","journal-title":"PloS One"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s11892-016-0794-7","article-title":"Salivary amylase: Digestion and metabolic syndrome","volume":"16","author":"Peyrot des Gachons","year":"2016","journal-title":"Curr Diabetes Rep"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01133-22","article-title":"Analysis of the prevalence of binding and neutralizing antibodies against 39 human adenovirus types in student cohorts reveals low-prevalence types and a decline in binding antibody levels during the sars-cov-2 pandemic","volume":"96","author":"Wang","year":"2022","journal-title":"J Virol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"105.3390\/v15010079","DOI":"10.3390\/v15010079","article-title":"Seroprevalence of binding and neutralizing antibodies against 39 human adenovirus types in patients with neuromuscular disorders","volume":"15","author":"Klann","year":"2022","journal-title":"Viruses"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1579896\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:54:14Z","timestamp":1749635654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1579896\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2025.1579896"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1579896","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"article-number":"1579896"}}